Inventor · name-matched record
NASVESCHUK CHRISTOPHER G
3 granted patents·3 pending applications·0 citations·filing 2021–2025
38Inventor score
Files withC4 THERAPEUTICS INC6
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
6 records- 0190US2026042782A1Isoindolinone and indazole compounds for the degradation of egfrC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0283US2026015362A1N/o-linked degrons and degronimers for protein degradationC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0373US2026015338A1Targeted protein degradationC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0470US12570626B2Degraders and degrons for targeted protein degradationC4 THERAPEUTICS INC·Filed 2022·Granted Mar 10, 2026·0 cites·16 claims
- 0558US12559492B2BRAF degradersC4 THERAPEUTICS INC·Filed 2022·Granted Feb 24, 2026·0 cites·23 claims
- 0655US12528797B2Heterocyclic compounds for medical treatmentC4 THERAPEUTICS INC·Filed 2021·Granted Jan 20, 2026·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when NASVESCHUK CHRISTOPHER G files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →